 - MS subjects who completed Study C-1801 NCT00027300, C-1802 NCT00030966, or C-1803 NCT00097760 and a Dosing Suspension Safety Evaluation neurological examination or a magnetic resonance imaging scan or participated in the IMA 04001 STARS Study 